anastrozole has been researched along with Cancer of Pituitary in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Most prolactinomas respond rapidly to low doses of dopamine agonists." | 1.31 | The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. ( Freed, DJ; Gillam, MP; Middler, S; Molitch, ME, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceccato, F | 1 |
| Lizzul, L | 1 |
| Voltan, G | 1 |
| Barbot, M | 1 |
| Scaroni, C | 1 |
| Gillam, MP | 1 |
| Middler, S | 1 |
| Freed, DJ | 1 |
| Molitch, ME | 1 |
2 other studies available for anastrozole and Cancer of Pituitary
| Article | Year |
|---|---|
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients.
Topics: Anastrozole; Cabergoline; Dopamine Agonists; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactin | 2021 |
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhi | 2002 |